The End of Public Health? An Introduction to the Symposium
Certain aspects of public health law as we know it are dead. In this symposium, we propose a path forward to create a “new public health” from the ashes.
Pharmaceuticals
-
Read more: The End of Public Health? An Introduction to the Symposium -
Read more: Losing Control of Controlled Substances? The Case of Telehealth Prescriptions Losing Control of Controlled Substances? The Case of Telehealth Prescriptions
In May 2022, the Department of Justice began investigating Cerebral for “possible violations” of the Controlled Substances Act.
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from December 2022.
-
Read more: Biotech Companies Are Opening Manufacturing Sites in Africa: Will This Help Vaccine Equity? Biotech Companies Are Opening Manufacturing Sites in Africa: Will This Help Vaccine Equity?
If pharma giants truly are committed to addressing vaccine inequity, just building manufacturing capacity in Africa might not be enough.
-
Read more: COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues
An explanation of the key patents at stake in the intellectual property dispute between Moderna and Pfizer/BioNTech over COVID-19 vaccines.
-
Read more: Bill of Health’s Top 10 Posts of 2022 Bill of Health’s Top 10 Posts of 2022
The top ten most-read articles published on Bill of Health in 2022.
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from November 2022.
-
Read more: Is Preemption the Cure for Healthcare Federalism’s Restrictions on Medication Abortion? Is Preemption the Cure for Healthcare Federalism’s Restrictions on Medication Abortion?
The consequences that result from state bans and restrictions on medication abortion represent just one example of “healthcare federalism.”
-
Read more: Falling Revenue Means Pharmacies in Italy Aren’t Keeping up with Other EU Countries Falling Revenue Means Pharmacies in Italy Aren’t Keeping up with Other EU Countries
Despite Italy being the fifth largest country in the EU for pharmaceutical expenditures, total revenue is dropping.
-
Read more: The Secret World of mRNA: HDT Bio Corp v. Emcure and Access to Next-Gen mRNA The Secret World of mRNA: HDT Bio Corp v. Emcure and Access to Next-Gen mRNA
The future of public health in an “RNA world” is on trial in a trade secrecy dispute worth $950 million.
